Aadi Bioscience, Inc. (AADI) Tops Q4 EPS by 15c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q4 EPS of ($0.52), $0.15 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $5.23 million versus the consensus estimate of $4.82 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• JPMorgan Downgrades Rakuten Inc. (4755:JP) (RKUNF) to Neutral
• JPMorgan Upgrades Tokyo Century (8439:JP) to Overweight